Cargando…
Chemokine Receptor-Targeted Therapies: Special Case for CCR8
SIMPLE SUMMARY: Antibodies directed at so-called immune checkpoint molecules represent a substantial improvement in cancer therapy. These biological reagents highlight the exquisite interplay between cancer and our own immune system. Cancer progression is enabled by establishing a compartment of sup...
Autor principal: | Moser, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833710/ https://www.ncbi.nlm.nih.gov/pubmed/35158783 http://dx.doi.org/10.3390/cancers14030511 |
Ejemplares similares
-
CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
por: Bogacka, Joanna, et al.
Publicado: (2022) -
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020) -
Targeting chemokine receptors in disease – a case study of CCR4
por: Solari, Roberto, et al.
Publicado: (2015) -
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies
por: Zheng, Diwei, et al.
Publicado: (2022)